Skip to content
Saturday, May 31, 2025
Latest:
  • Renewing hope: A global push to improve neonatal outcomes
  • FROM THE LABS: Cell Painting identifies flavonoids that are toxic to bladder cancer cells
  • Menopause 101
  • New technique offers lasting relief for slipping rib syndrome
  • Ready for space travel? GENESTAR can track how space affects your health
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu
Policywise

Not all risk is in the OR: How frailty and nutrition shape nephrectomy outcomes

May 23, 2025 Exercise,  frailty,  kidney cancer,  kidney surgery,  malnutrition,  Surgery

When we think of risks in surgery, our minds often go to human factors around the procedure itself, but some powerful predictors of surgical outcomes

Read More
From The Labs

PBRM1’s new function supports a novel cancer-promoting mechanism

October 14, 2021 Cancer,  chromatin remodeler,  cytoskleleton remodeler,  genomic instability,  kidney cancer,  PBRM1,  Research,  SETD2,  tubulin methylation

New findings suggest that cancer-associated defects in chromatin remodeler genes can drive cancer by disrupting cytoskeletal activities.

Read More
From The Labs

Playing with the physics of gels leads to a better kidney cancer treatment

May 14, 2020 cancer treatment,  FDA approved,  Jelmyto,  kidney cancer,  mitomycin,  Research,  UGN-101,  Urothelial cancer

Effectively treating upper tract urothelial cancer – a cancer of the lining of the kidney or the ureter, the long, thin tube that connects that

Read More
From The Labs

Chromosome remodeler SETD2 also remodels the cytoskeleton in kidney cancer cells

August 30, 2016 Cancer,  chromosome remodeler,  cytoskeleton remodeler,  epigenetics,  kidney cancer,  methyl tags,  Research,  SETD2

Kidney cancer begins when certain genes mutate and, as a result, alter how key molecules work. One of these key molecules is SETD2, which is

Read More

From the Labs: Image of the Month

Blood vessels (magenta) intertwined with metastatic medulloblastoma tumor cells (green) nestled within the protective layers that surround the mouse spinal cord. From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951